These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20971819)

  • 21. Difficult Diagnosis between B Cell Lymphoma and Classical Hodgkin's Lymphoma.
    Rentas Torres Y; Rodríguez-López JL; Valentin M; Silva H
    Bol Asoc Med P R; 2015; 107(3):98-101. PubMed ID: 26742206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.
    Gualco G; Weiss LM; Barber GN; Bacchi CE
    Hum Pathol; 2010 Sep; 41(9):1238-44. PubMed ID: 20382409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma.
    Kim HJ; Kim HK; Park G; Min SK; Cha HJ; Lee H; Choi SJ; Na HY; Choe JY; Kim JE
    Diagn Pathol; 2019 Dec; 14(1):133. PubMed ID: 31831043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement.
    Trump DL; Mann RB
    Cancer; 1982 Jul; 50(2):277-82. PubMed ID: 7044520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?
    Dunleavy K; Grant C; Eberle FC; Pittaluga S; Jaffe ES; Wilson WH
    Curr Hematol Malig Rep; 2012 Sep; 7(3):241-7. PubMed ID: 22833351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy.
    Gerrard M; Waxman IM; Sposto R; Auperin A; Perkins SL; Goldman S; Harrison L; Pinkerton R; McCarthy K; Raphael M; Patte C; Cairo MS;
    Blood; 2013 Jan; 121(2):278-85. PubMed ID: 23149845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma.
    Tanaka Y; Maeshima AM; Nomoto J; Makita S; Fukuhara S; Munakata W; Maruyama D; Tobinai K; Kobayashi Y
    Eur J Haematol; 2018 May; 100(5):511-517. PubMed ID: 29377256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Primary mediastinal (thymic) large B-cell lymphoma: review of the literature and author's own data].
    Kichigina MIu; Tumian GS; Kovrigina AM; Trofimova OP; Larionova VB; Chekan AA; Bykov DA; Osmanov DSh
    Ter Arkh; 2011; 83(7):38-46. PubMed ID: 21894750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liposomal-encapsulated doxorubicin supercharge-containing front-line treatment improves response rates in primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphoma.
    Picardi M; Giordano C; Pugliese N; Mascolo M; Varricchio S; Troncone G; Vigliar E; Bellavicine C; Lamagna M; Lisi D; Vincenzi A; Pane F
    Hematol Oncol; 2024 Jan; 42(1):e3242. PubMed ID: 38126215
    [No Abstract]   [Full Text] [Related]  

  • 30. Liposomal-encapsulated doxorubicin supercharge-containing front-line treatment improves response rates in primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphoma.
    Picardi M; Giordano C; Pugliese N; Mascolo M; Varricchio S; Troncone G; Vigliar E; Bellavicine C; Lamagna M; Lisi D; Vincenzi A; Pane F
    Hematol Oncol; 2024 Jan; 42(1):e3247. PubMed ID: 38287530
    [No Abstract]   [Full Text] [Related]  

  • 31. Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
    Gibson SE; Dojcinov S; Dotlic S; Hartmann S; Hsi ED; Klimkowska M; Melle F; Pileri SA; Ramsower CA; Rech K; Rimsza LM; Rodriguez-Pinilla SM; Tousseyn TA; de Jong D; Sabattini E
    Virchows Arch; 2023 Dec; 483(6):733-749. PubMed ID: 37530791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary mediastinal large B-cell lymphoma.
    Faris JE; LaCasce AS
    Clin Adv Hematol Oncol; 2009 Feb; 7(2):125-33. PubMed ID: 19367254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
    Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
    Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
    Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M
    Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.
    Giulino-Roth L; O'Donohue T; Chen Z; Bartlett NL; LaCasce A; Martin-Doyle W; Barth MJ; Davies K; Blum KA; Christian B; Casulo C; Smith SM; Godfrey J; Termuhlen A; Oberley MJ; Alexander S; Weitzman S; Appel B; Mizukawa B; Svoboda J; Afify Z; Pauly M; Dave H; Gardner R; Stephens DM; Zeitler WA; Forlenza C; Levine J; Williams ME; Sima JL; Bollard CM; Leonard JP
    Br J Haematol; 2017 Dec; 179(5):739-747. PubMed ID: 29082519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
    Popat U; Przepiork D; Champlin R; Pugh W; Amin K; Mehra R; Rodriguez J; Giralt S; Romaguera J; Rodriguez A; Preti A; Andersson B; Khouri I; Claxton D; de Lima M; Donato M; Anderlini P; Gajewski J; Cabanillas F; van Besien K
    J Clin Oncol; 1998 Jan; 16(1):63-9. PubMed ID: 9440724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase.
    Rodriguez J; Pugh WC; Romaguera JE; Luthra R; Hagemeister FB; McLaughlin P; Rodriguez MA; Swan F; Cabanillas F
    Ann Oncol; 1994 Nov; 5(9):847-9. PubMed ID: 7848887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mediastinal large B-cell lymphoma. A retrospective anatomic-clinical study of 26 cases].
    Tchen N; Eghbali H; Soubeyran P; Trojani M; Richaud P; Bonnel C; Quénel-Tueux N; Hoerni B
    Bull Cancer; 1997 Jul; 84(7):704-8. PubMed ID: 9339196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab.
    Papageorgiou SG; Diamantopoulos P; Levidou G; Angelopoulou MK; Economopoulou P; Efthimiou A; Constantinou N; Katsigiannis A; Korkolopoulou P; Pappa V; Economopoulou C; Georgiou G; Dimou M; Tsirigotis P; Kyrtsonis MC; Kotsianidis I; Kalpadakis C; Dimopoulos MA; Beris P; Meletis J; Pangalis GA; Dervenoulas J; Panayiotidis P; Vassilakopoulos TP
    Hematol Oncol; 2013 Mar; 31(1):10-7. PubMed ID: 22610484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric MLBL: challenges remain.
    Sandlund JT; Choi JK
    Blood; 2013 Jan; 121(2):245-6. PubMed ID: 23307971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.